1 – 57 of 57
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
(
- Contribution to journal › Article
- 2023
-
Mark
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
2023) In Virchows Archiv(
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Fibroblast subsets in non-small cell lung cancer : associations with survival, mutations, and immune features
(
- Contribution to journal › Article
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion
(
- Contribution to journal › Article
-
Mark
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
(
- Contribution to journal › Article
-
Mark
Difficulties in diagnostics of lung tumours in biopsies : An interpathologist concordance study evaluating the international diagnostic guidelines
(
- Contribution to journal › Article
- 2021
-
Mark
TGF-β-mediated epithelial–mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
The immune landscape of colorectal cancer
(
- Contribution to journal › Article
-
Mark
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
(
- Contribution to journal › Article
-
Mark
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
(
- Contribution to journal › Article
-
Mark
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
- 2020
-
Mark
Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
(
- Contribution to journal › Article
-
Mark
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
(
- Contribution to journal › Article
-
Mark
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
(
- Contribution to journal › Article
-
Mark
A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
A clonal expression biomarker associates with lung cancer mortality
(
- Contribution to journal › Letter
- 2018
-
Mark
An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases
(
- Contribution to journal › Article
-
Mark
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas
(
- Contribution to journal › Article
-
Mark
Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer
(
- Contribution to journal › Article
- 2017
-
Mark
The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
(
- Contribution to journal › Article
-
Mark
PD-L1 immunohistochemistry in clinical diagnostics of lung cancer : inter-pathologist variability is higher than assay variability
(
- Contribution to journal › Article
-
Mark
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO2015 classification
(
- Contribution to journal › Article
-
Mark
Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters
(
- Contribution to journal › Article
-
Mark
A pathology atlas of the human cancer transcriptome
(
- Contribution to journal › Article
- 2016
-
Mark
Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
-
Mark
The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.
(
- Contribution to journal › Article
-
Mark
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Profiling cancer testis antigens in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2015
-
Mark
LRIG1 is a prognostic biomarker in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
2015) In Applied Immunohistochemistry & Molecular Morphology(
- Contribution to journal › Article
-
Mark
Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression.
(
- Contribution to journal › Article
- 2014
-
Mark
Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
(
- Contribution to journal › Article
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
-
Mark
A systematic analysis of commonly used antibodies in cancer diagnostics
(
- Contribution to journal › Article
- 2013
-
Mark
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status.
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
(
- Contribution to journal › Article
- 2012
-
Mark
CD99 is a novel prognostic stromal marker in non-small cell lung cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer.
(
- Contribution to journal › Article
- 2009
-
Mark
Prognostic Significance of Stromal Platelet-Derived Growth Factor beta-Receptor Expression in Human Breast Cancer
(
- Contribution to journal › Article
-
Mark
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
(
- Contribution to journal › Article
- 2003
-
Mark
Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications
(
- Contribution to journal › Article